Since last summer, former takeover target Lifeway Foods has become a growth story. Given steady sales growth, plus factors like new product launches and a fatory expansion, could drive a large increase in profitability. That said, execution risk remains, so even those bullish on this changed "story" may want to wait for further weakness before buying.
Lifeway Foods remains undervalued relative to its robust growth outlook, with a buy rating and a $27.52 price target—26% above current levels. LWAY delivered 24% GAAP revenue growth in 3Q 2025, beat guidance, and reiterated strong EBITDA targets despite ongoing factory upgrades and margin pressure. Family boardroom disputes and buyout speculation have pressured the stock, but institutional investors and management remain focused on long-term growth.
Lifeway Foods demonstrates strong long-term potential in the consumer packaged goods sector, driven by its kefir and farmers cheese products. LWAY has achieved significant revenue growth since mid-2024, showcasing resilience despite internal family drama and external takeover attempts. The company remains founder-led, which has contributed to its consistent execution and ability to navigate challenges effectively.
Lifeway Foods remains a compelling buy, driven by strong kefir demand and robust sales growth despite the failed Danone acquisition. LWAY holds an estimated 28% share of the North American kefir market and is expanding internationally, with production capacity set to double by 2026. The company projects 17.6%–20% annual revenue growth, supported by expanded distribution and a factory upgrade, justifying a higher valuation.
Q1 2025 Earnings Conference Call May 13, 2025 9:00 AM ET Company Participants John Mills - Investor Relations Julie Smolyansky - President and Chief Executive Officer Conference Call Participants John Mills Good morning. Welcome to Lifeway Foods First Quarter 2025 Conference Call.
In the closing of the recent trading day, Lifeway Foods (LWAY) stood at $21.49, denoting a +0.7% change from the preceding trading day.
Lifeway Foods has rejected not one, but two takeover offers from Danone, but the kefir and fermented probiotic food products company remains "in play." The latest in an ongoing saga amongst the company's founding family may prove key in driving the company into the hands of this would-be strategic acquirer. More importantly for new and existing LWAY shareholders, this could result in Danone ultimately paying as much as $35 per share for the company.
LWAY continues its impressive growth streak, marking 20 consecutive quarters of rising sales.
Lifeway Foods, Inc. (NASDAQ:LWAY ) Q3 2024 Earnings Conference Call November 14, 2024 9:00 AM ET Company Participants Julie Smolyansky - President and Chief Executive Officer Conference Call Participants Operator Good morning. Welcome to Lifeway Foods' Third Quarter 2024 Conference Call.
Lifeway Foods (LWAY) came out with quarterly earnings of $0.19 per share, missing the Zacks Consensus Estimate of $0.27 per share. This compares to earnings of $0.23 per share a year ago.
Regular readers of my writeups know that I am a huge fan of trading momentum stocks, as momentum is one of the market's premier anomalies. But when investors combine momentum with the Zacks Rank, they really get something special.
Does Lifeway Foods (LWAY) have what it takes to be a top stock pick for momentum investors? Let's find out.